Hendrik Schafer
Overview
Explore the profile of Hendrik Schafer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
927
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schafer H, Lajmi N, Valente P, Pedrioli A, Cigoianu D, Hoehne B, et al.
Diagnostics (Basel)
. 2025 Mar;
15(5).
PMID: 40075895
In a rapidly changing technology landscape, "Clinical Decision Support" (CDS) has become an important tool to improve patient management. CDS systems offer medical professionals new insights to improve diagnostic accuracy,...
2.
Geib K, Scharf S, Schafer H, Hartmann S, Hansmann M, Wurzel P
Acta Histochem
. 2025 Jan;
127(1):152232.
PMID: 39883976
Follicular lymphoma (FL) represents the most prevalent subtype of non-Hodgkin's-lymphoma in Western Europe and the United States. While the examination of two-dimensional histological slides remains the gold standard method for...
3.
Baudin N, Garrod M, Bramke I, Mckillican C, Schafer H, Hand L, et al.
Environ Monit Assess
. 2025 Jan;
197(2):207.
PMID: 39883222
Brazilian soils have distinctive characteristics to European and North American soils which are typically used to investigate pesticide fate. This study aimed to compare soil-water partition coefficient (K), reversibility of...
4.
Garbsch R, Schafer H, Mooren F, Schmitz B
Clin Nutr
. 2024 Oct;
43(12):26-35.
PMID: 39423759
Background & Aims: Post-COVID-19 Syndrome (PCS) is characterized by symptoms including fatigue, reduced physical performance, dyspnea, cognitive impairment, and psychological distress. The mechanisms underlying the onset and severity of PCS...
5.
Garbsch R, Schafer H, Kotewitsch M, Mooren J, Waranski M, Teschler M, et al.
BMC Med
. 2024 Oct;
22(1):446.
PMID: 39379918
Background: Post-COVID-19 Syndrome (PCS) entails a spectrum of symptoms, including fatigue, reduced physical performance, dyspnea, cognitive impairment, and psychological distress. Given the effectiveness of exercise-based rehabilitation for PCS, this study...
6.
Sherif M, Schafer H, Scharf S, van Oostendorp V, Sadeghi Shoreh Deli A, Loth A, et al.
Br J Haematol
. 2024 Oct;
205(6):2327-2337.
PMID: 39355919
Diffuse large B-cell lymphoma (DLBCL) represents the most prevalent aggressive B-cell lymphoma. The group is heterogeneous and the outcome is variable. A variety of approaches have been employed with the...
7.
Luo W, Zhao M, Dwidar M, Gao Y, Xiang L, Wu X, et al.
Microbiome
. 2024 Aug;
12(1):152.
PMID: 39152482
Background: HS imbalances in the intestinal tract trigger Crohn's disease (CD), a chronic inflammatory gastrointestinal disorder characterized by microbiota dysbiosis and barrier dysfunction. However, a comprehensive understanding of HS generation...
8.
Yadigaroglu K, Scharf S, Gretser S, Schafer H, Sadeghi Shoreh Deli A, Loth A, et al.
Haematologica
. 2024 May;
109(10):3295-3304.
PMID: 38779721
Although checkpoint molecules like CTLA-4 and PD1 have been described several years ago, checkpoint inhibitors such as nivolumab (an anti-PD-1 antibody) have only recently been used to treat classic Hodgkin...
9.
Douma E, Wirtz S, Fernandez M, Schafer H, Widdershoven J, Habibovic M, et al.
Internet Interv
. 2024 Feb;
35:100728.
PMID: 38405384
Background: Cardiac rehabilitation (CR) reduces recurrent cardiac events and mortality in patients with cardiovascular diseases (CVD). Innovative eHealth methods can facilitate CR uptake and effectiveness by addressing barriers associated with...
10.
Schmitz B, Wirtz S, Sestayo-Fernandez M, Schafer H, Douma E, Alonso Vazquez M, et al.
J Med Internet Res
. 2024 Feb;
26:e53991.
PMID: 38386376
Background: The use of eHealth technology in cardiac rehabilitation (CR) is a promising approach to enhance patient outcomes since adherence to healthy lifestyles and risk factor management during phase III...